meningeal
Showing 26 - 50 of 391
Biomechanical Coupling of Brain and Skull
Recruiting
- Traumatic Brain Injury (Tbi)
- Traumatic Meningeal Enhancement (Tme)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Tuberculous Meningitis, Tuberculous Arachnoiditis Trial in New Delhi (MRI Brain and spine, Reference standard diagnostic
Recruiting
- Tuberculous Meningitis
- Tuberculous Arachnoiditis
- MRI Brain and spine
- Reference standard diagnostic criteria
-
New Delhi, Delhi, IndiaAll India Institute of Medical Sciences, New Delhi
Nov 23, 2022
Chronic Subdural Hematoma Trial in Winnipeg (Embolization of the Middle Meningeal Artery)
Recruiting
- Chronic Subdural Hematoma
- Embolization of the Middle Meningeal Artery
-
Winnipeg, Manitoba, CanadaUniversity of Manitoba
Sep 13, 2021
Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)
Terminated
- Breast Cancer Female
- Leptomeningeal Metastases
- HER2 BATs
-
Charlottesville, VirginiaUniversity of Virginia
Dec 15, 2022
Tuberculosis, Extrapulmonary Trial in South Africa, Zambia, Zimbabwe (IRISA-TB)
Recruiting
- Tuberculosis, Extrapulmonary
- IRISA-TB
-
Durban, KwaZulu-Natal, South Africa
- +3 more
Nov 13, 2023
Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)
Active, not recruiting
- Leptomeningeal Metastases
- Leptomeningeal Disease
- Avelumab
- Whole Brain Radiotherapy
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Radiation Therapy
- +2 more
-
Tampa, Florida
- +1 more
Dec 30, 2022
Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)
Not yet recruiting
- Tuberculous Meningitis
- HIV I Infection
- Adalimumab Injection
-
Rio De Janeiro, Brazil
- +2 more
Jan 31, 2023
Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)
Recruiting
- Leptomeningeal Disease
- +2 more
- Dendritic Cell Vaccine
-
Tampa, FloridaMoffitt Cancer Center
Apr 11, 2023
based Approaches for Improving Diagnosis of Childhood
Recruiting
- Tuberculous Meningitis
-
Cape Town, Western Cape, South AfricaStellenbosch University Immunology Research Group
May 16, 2022
Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)
Not yet recruiting
- Tuberculous Meningitis
- High dose rifampicin (25mg/kg)
- +8 more
-
Chennai, Tamil Nadu, IndiaICMR- National Institute for Research in Tuberculosis
Jun 15, 2023
CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)
Available
- Central Nervous System/Leptomeningeal Neoplasms
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 15, 2022
Spina Bifida, Myelomeningocele, Myeloschisis Trial in Houston (NEOX Cord 1K applied fetoscopically)
Recruiting
- Spina Bifida
- +2 more
- NEOX Cord 1K applied fetoscopically
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 14, 2022
Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and
Recruiting
- Leptomeningeal Metastasis
- +2 more
- intrathecal nivolumab and intrathecal ipilimumab
-
Geneva, Switzerland
- +2 more
Dec 18, 2022
Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)
Recruiting
- Leptomeningeal Metastasis
- +2 more
- Camrelizumab or envafolimab
-
Hebei, ChinaThe Second Hospital of Hebei Medical University
May 19, 2022
Chronic Subdural Hematoma Trial in New York (Middel Meningeal Artery Embolization)
Completed
- Chronic Subdural Hematoma
- Middel Meningeal Artery Embolization
-
New York, New YorkWeill Cornell Medical College
Mar 2, 2021
Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)
Recruiting
- Leptomeningeal Metastases
- Pemetrexed (1)
- +4 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 29, 2022
Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])
Recruiting
- Leptomeningeal Disease
- Nivolumab [Opdivo]
-
Freiburg, Germany
- +6 more
Nov 2, 2022
Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR
Not yet recruiting
- Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
- +6 more
- (no location specified)
Aug 9, 2022
Chronic Subdural Hematoma Trial in Barcelona (Post surgical embolization of middle meningeal artery with liquid embolic agents
Recruiting
- Chronic Subdural Hematoma
- Post surgical embolization of middle meningeal artery with liquid embolic agents (ethylene vinyl alcohol copolymers as Onix, Squid, Phil or Libro)
-
Barcelona, SpainHospital Universitari Vall d'Hebron
Mar 4, 2022
Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)
Recruiting
- Leptomeningeal Metastasis
- Pemetrexed
- Radiotherapy
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 8, 2022
Tuberculosis, Meningeal Trial in Pune, Chennai, Lilongwe (High-dose: RIF, INH, PZA, EMB, High dose: RIF, INH, PZA, LEVO,
Completed
- Tuberculosis, Meningeal
- High-dose: RIF, INH, PZA, EMB
- +2 more
-
Pune, Maharashtra, India
- +2 more
Oct 27, 2021
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)
Recruiting
- NSCLC
- +3 more
- TY-9591 Tablets
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022
NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line
Recruiting
- NSCLC
- +2 more
- almonertinib
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 25, 2021